Anteris Technologies Global Corp (AVR) - Total Assets
Based on the latest financial reports, Anteris Technologies Global Corp (AVR) holds total assets worth AU$19.07 Million AUD (≈ $13.50 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Anteris Technologies Global Corp for net asset value and shareholders' equity analysis.
Anteris Technologies Global Corp - Total Assets Trend (2003–2024)
This chart illustrates how Anteris Technologies Global Corp's total assets have evolved over time, based on quarterly financial data.
Anteris Technologies Global Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Anteris Technologies Global Corp's total assets of AU$19.07 Million consist of 92.5% current assets and 7.5% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 87.3% |
| Accounts Receivable | AU$2.25 Million | 1.7% |
| Inventory | AU$828.85K | 0.6% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$305.37K | 0.2% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2003–2024)
This chart illustrates how Anteris Technologies Global Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Anteris Technologies Global Corp stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Anteris Technologies Global Corp's current assets represent 92.5% of total assets in 2024, an increase from 73.4% in 2003.
- Cash Position: Cash and equivalents constituted 87.3% of total assets in 2024, up from 73.4% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 22.0% in 2003.
- Asset Diversification: The largest asset category is accounts receivable at 1.7% of total assets.
Anteris Technologies Global Corp Competitors by Total Assets
Key competitors of Anteris Technologies Global Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Sino Medical Sciences Technology In
SHG:688108
|
China | CN¥1.34 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$127.41 Million |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.75 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.00 Billion |
|
Respiri Ltd
AU:RSH
|
Australia | AU$7.08 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Atomo Diagnostics Ltd
AU:AT1
|
Australia | AU$9.48 Million |
Anteris Technologies Global Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.84 | 0.96 | 1.03 |
| Quick Ratio | 0.80 | 0.92 | 0.94 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$-2.21 Million | AU$-784.36K | AU$253.37K |
Anteris Technologies Global Corp - Advanced Valuation Insights
This section examines the relationship between Anteris Technologies Global Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 148.85 |
| Latest Market Cap to Assets Ratio | 4.28 |
| Asset Growth Rate (YoY) | 185.3% |
| Total Assets | AU$130.39 Million |
| Market Capitalization | $558.50 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Anteris Technologies Global Corp's assets at a significant premium (4.28x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Anteris Technologies Global Corp's assets grew by 185.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Anteris Technologies Global Corp (2003–2024)
The table below shows the annual total assets of Anteris Technologies Global Corp from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | AU$130.39 Million ≈ $92.26 Million |
+185.30% |
| 2023-12-31 | AU$45.70 Million ≈ $32.34 Million |
+94.64% |
| 2022-12-31 | AU$23.48 Million ≈ $16.61 Million |
-20.36% |
| 2021-12-31 | AU$29.48 Million ≈ $20.86 Million |
+133.03% |
| 2020-12-31 | AU$12.65 Million ≈ $8.95 Million |
-51.35% |
| 2019-12-31 | AU$26.00 Million ≈ $18.40 Million |
-18.38% |
| 2018-12-31 | AU$31.86 Million ≈ $22.54 Million |
+12.30% |
| 2017-12-31 | AU$28.37 Million ≈ $20.07 Million |
-0.73% |
| 2016-12-31 | AU$28.58 Million ≈ $20.22 Million |
+6.71% |
| 2015-12-31 | AU$26.78 Million ≈ $18.95 Million |
-35.10% |
| 2014-12-31 | AU$41.26 Million ≈ $29.19 Million |
+3.77% |
| 2013-12-31 | AU$39.76 Million ≈ $28.13 Million |
+140.05% |
| 2012-12-31 | AU$16.56 Million ≈ $11.72 Million |
+47.92% |
| 2011-12-31 | AU$11.20 Million ≈ $7.92 Million |
-24.07% |
| 2010-12-31 | AU$14.75 Million ≈ $10.44 Million |
+954.79% |
| 2009-12-31 | AU$1.40 Million ≈ $989.32K |
+7.45% |
| 2008-12-31 | AU$1.30 Million ≈ $920.69K |
-16.80% |
| 2007-12-31 | AU$1.56 Million ≈ $1.11 Million |
-39.47% |
| 2006-12-31 | AU$2.58 Million ≈ $1.83 Million |
-34.15% |
| 2005-12-31 | AU$3.92 Million ≈ $2.78 Million |
+2.53% |
| 2004-12-31 | AU$3.83 Million ≈ $2.71 Million |
-24.49% |
| 2003-12-31 | AU$5.07 Million ≈ $3.59 Million |
-- |
About Anteris Technologies Global Corp
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calci… Read more